Literature DB >> 30882596

Blood pressure, antihypertensive medication use, and risk of erectile dysfunction in men with type I diabetes.

Aruna V Sarma1, James M Hotaling2, Ian H de Boer3, Rodney L Dunn1, Mary K Oerline1, Karandeep Singh4, Jack Goldberg5, Alan Jacobson6, Barbara Braffett7, William H Herman8, Rodica Pop-Busui8, Hunter Wessells9.   

Abstract

OBJECTIVE: To gain insight into the effect of blood pressure on the pathophysiology of diabetic erectile dysfunction, we determined the onset, severity and treatment of hypertension and risk of incident erectile dysfunction in men with type I diabetes.
METHODS: This prospective cohort study included 692 men without prevalent erectile dysfunction in the Epidemiology of Diabetes Interventions and Complications study. Erectile dysfunction was assessed yearly for 16 years with a single question querying presence of impotence. Multivariable cox proportional hazards models examined associations of hypertension variables with risk for incident erectile dysfunction.
RESULTS: Over 7762 person-years of follow-up, 337 of 692 men reported incident erectile dysfunction representing an unadjusted rate of 43.4 cases per 1000 person-years. Risk of erectile dysfunction significantly increased with each 10 mmHg of SBP elevation for those not taking antihypertensive medications, after adjustment for age, cigarette smoking and HbA1c levels [relative risk (RR) = 1.21, 95% CI = 1.04-1.41]. This relationship disappeared among those reporting antihypertensive medication use (RR = 0.96, 95% CI = 0.84-1.10) and the interaction between SBP and medication use was statistically significant (P = 0.02). Antihypertensive medication did not confer any reduction of erectile dysfunction risk, with similar rates across all measures of blood pressure and hypertension.
CONCLUSION: Among men with type 1 diabetes not using antihypertensive medications, higher SBP is associated with increased risk of developing erectile dysfunction. These findings provide evidence to support further investigation into the potential benefit of early blood pressure control on risk of erectile dysfunction in men with diabetes regardless of age, blood pressure level, or glycemic control.

Entities:  

Year:  2019        PMID: 30882596      PMCID: PMC7223638          DOI: 10.1097/HJH.0000000000001988

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  27 in total

Review 1.  Urologic complications of diabetes.

Authors:  Jeanette S Brown; Hunter Wessells; Michael B Chancellor; Stuart S Howards; Walter E Stamm; Ann E Stapleton; William D Steers; Stephen K Van Den Eeden; Kevin T McVary
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

2.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

3.  Predictors and prevalence of erectile dysfunction in a racially diverse population.

Authors:  Christopher S Saigal; Hunter Wessells; Jennifer Pace; Matt Schonlau; Timothy J Wilt
Journal:  Arch Intern Med       Date:  2006-01-23

4.  Erectile dysfunction and subsequent cardiovascular disease.

Authors:  Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; Jeffrey L Probstfield; Carol M Moinpour; Charles A Coltman
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

5.  New insights into hypertension-associated erectile dysfunction.

Authors:  Kenia Pedrosa Nunes; Hicham Labazi; R Clinton Webb
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-03       Impact factor: 2.894

6.  Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes.

Authors:  Hunter Wessells; David F Penson; Patricia Cleary; Brandy N Rutledge; John M Lachin; Kevin T McVary; David S Schade; Aruna V Sarma
Journal:  J Urol       Date:  2011-03-21       Impact factor: 7.450

7.  Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.

Authors: 
Journal:  JAMA       Date:  2003-10-22       Impact factor: 56.272

8.  Captopril treatment reverses erectile dysfunction in male stroke prone spontaneously hypertensive rats.

Authors:  A M Dorrance; R W Lewis; T M Mills
Journal:  Int J Impot Res       Date:  2002-12       Impact factor: 2.896

9.  Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial.

Authors:  Raymond C Rosen; Rena R Wing; Stephen Schneider; Thomas A Wadden; Gary D Foster; Delia Smith West; Abbas E Kitabchi; Frederick L Brancati; Barbara J Maschak-Carey; Judy L Bahnson; Cora E Lewis; Isaias N Gendrano Iii
Journal:  J Sex Med       Date:  2009-01-31       Impact factor: 3.802

10.  The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.

Authors:  David M Nathan
Journal:  Diabetes Care       Date:  2014       Impact factor: 19.112

View more
  2 in total

Review 1.  Erectile dysfunction and diabetes: A melting pot of circumstances and treatments.

Authors:  Giuseppe Defeudis; Rossella Mazzilli; Marta Tenuta; Giovanni Rossini; Virginia Zamponi; Soraya Olana; Antongiulio Faggiano; Paolo Pozzilli; Andrea M Isidori; Daniele Gianfrilli
Journal:  Diabetes Metab Res Rev       Date:  2021-09-21       Impact factor: 8.128

2.  Association between erectile dysfunction, cardiovascular risk factors, and coronary artery disease: Role of exercise stress testing and International Index of Erectile Function (IIEF-5) questionnaire.

Authors:  Shakeel Ahmed Memon; Muhammad Adil; Fahad Raja Khan; Safi Ullah; Samra Rehmat; Nooh Zad Gul
Journal:  Int J Cardiol Heart Vasc       Date:  2022-04-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.